Testing a New Psychiatric Medication for Multiple Mental Health Conditions

This is an early-stage research study testing psilocybin, a naturally occurring compound, as a potential treatment for people whose psychiatric symptoms—like depression, anxiety, PTSD, or addiction—are making it hard to function in daily life. The study will give you one oral dose of the medication and then monitor how safe it is and how you respond to it over the following weeks and months. The researchers want to understand whether this treatment could help people with multiple different psychiatric conditions, not just one specific diagnosis.

Most psychiatric research has focused narrowly on single diagnoses with strict eligibility rules, which may not reflect how complex real-world patients actually are. This study exists to test whether this medication is safe and feasible for people with overlapping or multiple psychiatric conditions and significant functional impairment—a more realistic picture of who might benefit from it.